Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of ritodrine hydrochloride plus medroxyprogesterone acetate for threatened preterm labor
jRCT1061250064Recruiting
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ritodrine and medroxyprogesterone acetate in Preterm labor (PTL) (2 arms). Primary endpoint: Maternal adverse events related to medroxyprogesterone acetate and ritodrine hydrochloride. Started Mar 2026; status: recruiting.
02
Drugs
ritodrinemedroxyprogesterone acetate
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on jRCT1061250064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061250064.